Baird Maintains Outperform on Accendra Health, Raises Price Target to $6
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Baird analyst Eric Coldwell maintains Accendra Health (NYSE:ACH) with a Outperform and raises the price target from $5 to $6.
Baird analyst Eric Coldwell maintains Accendra Health (NYSE:ACH) with a Outperform and raises the price target from $5 to $6.